~~<i id='1DE02CFBBC'><strike id='1DE02CFBBC'><tt id='1DE02CFBBC'><pre id='1DE02CFBBC'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：leisure time 2025-10-02 12:37:24 Page View：272

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： US judge blocks portions of new Florida elections law
Next article： Alkermes shareholders re

explore

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

ZaremaMusayevsitsbehindbarsinacourtroomainGrozny,Russia,Tuesday,July4,2023.Musayevisthemotheroftwolo

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Photoillustration:STAT;Photo:AdobeThreeyearsago,JamieLin,anearly-careernephrologistatMDAndersonCance